Savient Pharmaceuticals (SVNT) Posts Q4 Loss of 44c/Sh., Misses Views

February 27, 2012 7:04 AM EST
Get Alerts SVNT Hot Sheet
Trade SVNT Now!
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q4 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $3.71 million versus the consensus estimate of $3.51 million.

For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment